Quarterly Result23 Oct 2026, 04:40 pm
Torrent Pharma Board Approves Q2 & H1 FY27 Financial Results
AI Summary
Torrent Pharmaceuticals Ltd announced that its Board of Directors has approved the Audited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The company will publish extracts of the consolidated results as per SEBI regulations. Both standalone and consolidated financial results will be available on the company's website. A press release detailing the financial results has also been prepared. The Board meeting took place from 2:00 PM to 4:00 PM.
Key Highlights
- Board approved standalone and consolidated financial results.
- Results are for the quarter and half-year ended September 30, 2026.
- Financial results will be available on the company website.
- Audited standalone and limited review consolidated reports were approved.
Price Impact
More from TORNTPHARM